Technology
Positive
Nilo Therapeutics launches with $101 million Series A financing to advance a new class of medicines targeting neural circuits in immune disease and appoints Kim Seth as Chief Executive Officer
Breaking news from global financial markets
1 month ago
Read More
1 month ago
1,567
1 month ago
3,978
1 month ago
4,617
1 month ago
4,698
1 month ago
1,416
1 month ago
652
1 month ago
3,022
1 month ago
2,560
1 month ago
2,626
Why Immuron Is Rising In Pre-market?
Technology
1 month ago
1,138
1 month ago
1,667
1 month ago
3,922
1 month ago
4,818
1 month ago
2,973
1 month ago
3,647
NFC Forum Welcomes NuCurrent to its Board
Technology
1 month ago
4,343
Stock Market Performance: Indexes Extend Gains from April Lows, but Participation Remains Uneven
Technology
1 month ago
505
1 month ago
2,146
Trending Now
1
Consumer Portfolio Services GAAP EPS of $0.20, revenue of $108.4M
35,167
1 hour ago
2
SoftBank unloads entire stake in Nvidia for $5.8B
10,236
1 hour ago
3
EUR/USD holds in range as US government reopening hopes lift mood
27,575
1 hour ago
4
5
NZD/USD hovers around 0.5640, downside likely on RBNZ rate cut bets
2,029
1 hour ago